FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+2.15%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-12%)
Cap. Flow
-$17.5M
Cap. Flow
% of AUM
-15.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Novavax
NVAX
|
$13.9M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$3.29M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$375K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$1.74B
| $112M | 99.68% | 750,000 | – | – |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $359K | 0.32% | 143,759 -150,000 | -51% | -$375K |
|
|
3
Novavax
NVAX
$1.21B
| – | – | -66,810 | Closed | -$13.9M |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| – | – | -19,100 | Closed | -$3.29M |
|